Evidence map›Paper›PMID 30237457›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2019

Poldip2 knockdown inhibits vascular smooth muscle proliferation and neointima formation by regulating the expression of PCNA and p21.

Srinivasa Raju Datla, Lula L Hilenski, Bonnie Seidel-Rogol, Anna E Dikalova, Mark Harousseau, Lili Punkova, Giji Joseph, W Robert Taylor, Bernard Lassègue, Kathy K Griendling

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Total Panax notoginseng saponin inhibits balloon injury-induced neointimal hyperplasia in rat carotid artery models by suppressing pERK/p38 MAPK pathways.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
  8. The pathophysiological basis of vascular disease.Laboratory investigation; a journal of technical methods and pathology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Srinivasa Raju DatlaDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Lula L HilenskiDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Bonnie Seidel-RogolDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Anna E DikalovaDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Mark HarousseauDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Lili PunkovaDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Giji JosephDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
W Robert TaylorDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Bernard LassègueDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA.
Kathy K GriendlingDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, GA, 30322, USA. kgriend@emory.edu.
Emory University · USAtlanta Medical Center · US

Funding

T cell triggering events and hypertensionP01HL095070 · NHLBI · EMORY UNIVERSITY · PI JO, HANJOONG · 2009 to 2019
$20.5M
NOX4 and vascular smooth muscle differentiationR37HL038206 · NHLBI · EMORY UNIVERSITY · PI GRIENDLING, KATHY K · 2006 to 2015
$3.8M
VASCULAR SMOOTH MUSCLE PHOSPHOLIPASE DR01HL038206 · NHLBI · EMORY UNIVERSITY · PI GRIENDLING, KATHY K · 1993 to 2005
$2.1M
NHLBI NIH HHS P01 HL095070NHLBI NIH HHS R01 HL038206NHLBI NIH HHS R37 HL038206
6 · The paper itself

Abstract

Polymerase delta-interacting protein 2 (Poldip2) is a multi-functional protein with numerous roles in the vasculature, including the regulation of cell apoptosis and migration, as well as extracellular matrix deposition; however, its role in VSMC proliferation and neointimal formation is unknown. In this study, we investigated the role of Poldip2 in intraluminal wire-injury induced neointima formation and proliferation of vascular smooth muscle cells in vitro and in vivo. Poldip2 expression was observed in the intima and media of human atherosclerotic arteries, where it colocalized with proliferating cell nuclear antigen (PCNA). Wire injury of femoral arteries of Poldip2

Indexed as

AnimalsAtherosclerosisCarrier ProteinsCell ProliferationCyclin-Dependent Kinase Inhibitor p21Down-RegulationGene Knockdown TechniquesHumansMiceMice, KnockoutMitochondrial ProteinsMuscle, Smooth, VascularMyocytes, Smooth MuscleNeointimaNuclear ProteinsProliferating Cell Nuclear AntigenCarrier ProteinsCyclin-Dependent Kinase Inhibitor p21Mitochondrial Proteinsmitogenin 1 protein, mouseNuclear ProteinsPOLDIP2 protein, humanPoldip2 protein, ratProliferating Cell Nuclear AntigenRNA, Small InterferingSuperoxides

Identifiers

PMID30237457
PMCPMC6393166
OpenAlexW2890917459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.